Showing 1 - 3 of 3
Pfizer sees high demand for Covid-19 pill as profits jump
AFP, Published on 04/05/2022
» NEW YORK: Pfizer executives said Tuesday they are confident of strong demand for the company's Covid-19 antiviral treatment amid easing pandemic rules as the big drugmaker reported another round of strong earnings.
Drugmakers Reap Billions Meeting Covid-19 Needs
Business, Peter Loftus, Published on 28/02/2022
» Healthcare companies that came up with effective Covid-19 vaccines, treatments and tests are seeing a huge financial payoff and are starting to spend their cash, while grappling with questions about whether the growth is sustainable.
Pfizer sees Covid-19 drug sales topping $50bn in 2022
AFP, Published on 09/02/2022
» NEW YORK - Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation.